Výsledky vyhledávání - "Associazione Italiana per la Ricerca sul Cancro AGIMM Gruppo Italiano Malattie Mieloproliferative"

Akademický článek

mTOR inhibitors alone and in combination with JAK2 inhibitors effectively inhibit cells of myeloproliferative neoplasms.

Autor: Costanza Bogani, Niccolò Bartalucci, Serena Martinelli, Lorenzo Tozzi, Paola Guglielmelli, Alberto Bosi, Alessandro M Vannucchi, Associazione Italiana per la Ricerca sul Cancro AGIMM Gruppo Italiano Malattie Mieloproliferative

Publikováno v: PLoS ONE, Vol 8, Iss 1, p e54826 (2013)

BACKGROUND:Dysregulated signaling of the JAK/STAT pathway is a common feature of chronic myeloproliferative neoplasms (MPN), usually associated with JAK2V617F mutation. Recent clinical trials with JAK2 inhibitors showed significant improvements in sp

Externí odkaz: https://doaj.org/article/be809609d2ff41919619b1559796b443

Zobrazit plný text záznamu

mTOR inhibitors alone and in combination with JAK2 inhibitors effectively inhibit cells of myeloproliferative neoplasms

Publikováno v: PLoS ONE
PLoS ONE, Vol 8, Iss 1, p e54826 (2013)

Background Dysregulated signaling of the JAK/STAT pathway is a common feature of chronic myeloproliferative neoplasms (MPN), usually associated with JAK2V617F mutation. Recent clinical trials with JAK2 inhibitors showed significant improvements in sp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d9d87b6ebf6e6a69bd8fad0dabb76a8
https://pubmed.ncbi.nlm.nih.gov/23382981

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání